Sign in
CompletedNo phase

Assessment of Er:YAG Laser-Assisted Surgical Treatment in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Clinical Trial

Key facts

Who runs it
Wroclaw Medical University
Where
Poland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
65 people enrolled
Started
1 Feb 2021
Ended
1 May 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • irradiation with Er:YAG laser
  • Tissue preparation
Record updated
19 June 2025

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • confirmed diagnosis of MRONJ

Who cannot take part

  • head and neck radiotherapy
  • cases requiring hospital admission due to poor general condition

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study is assessing the effectiveness of the Er:YAG laser in relation to the use of conventional surgery in the treatment of drug-induced osteonecrosis of the jaws (MRONJ). The study compares two main treatments for advanced cases of MRONJ or cases that do not show improvement despite conservative or non-surgical treatment.

The 2 groups in the trial

  • Patients treated with the Er:YAG laserTreatment being tested

    Treatment: irradiation with Er:YAG laser

  • Patients treated with the conventional surgeryExisting treatment, for comparison

    Treatment: Tissue preparation

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Assessment of Er:YAG (Yttrium-aluminium-garnet) Laser-Assisted Surgical Treatment in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Clinical Trial
Record updated
19 June 2025